- Home
- SNTI
as 12-18-2024 1:42pm EST
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 10.4M | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 7.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -15.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.52 - $16.94 | Next Earning Date: | 11-14-2024 |
| Revenue: | N/A | Revenue Growth: | -40.25% |
| Revenue Growth (this year): | 254.47% | Revenue Growth (next year): | 169.66% |
Latest Senti Biosciences Inc. News
SNTI Breaking Stock News: Dive into SNTI Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Senti Biosciences Reports First Patient Dosed in Trial of SN301A in Hepatocellular Carcinoma
GlobeNewswire
2 days ago
Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics
TipRanks
13 days ago
Senti Bio price target raised to $12 from $10 at Chardan
GlobeNewswire
15 days ago
Senti Biosciences Announces New Employment Inducement Grants
Zacks
15 days ago
SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study
TipRanks
15 days ago
Senti Bio reports positive initial clinical data from Phase 1 trial of SENTI-202
MT Newswires
16 days ago
Sector Update: Health Care Stocks Slipping Late Afternoon
MT Newswires
16 days ago
Sector Update: Health Care Stocks Softer Monday Afternoon
Compare SNTI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNTI Senti Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.